AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03626883 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: single-bundle, double-hamstring ACL reconstruction
Description: anterior cruciate ligament reconstruction with 2 hamstring tendons
Study NCT00262639 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 20 mg Saline infused slowly over 20 minutes. Placebo 1 capsule Day 1, 2 capsules Day 2, 3 capsules Day 3, 4 capsules days 4 to 30; 3 capsules Day 31 to 33; 2 capsules day 34 to 36 and 1 capsule 37 to 39.
Study NCT03358004 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vinorelbine Tartrate
Description: Metronomic treatment with vinorelbine 50 mg (three times/week) until progression in ARM A
Study NCT03358004 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine 500 MG
Description: Metronomic treatment with capecitabine 500 mg (three times/day) combined with vinorelbine 40 mg (three times/week) with until progression
Study NCT04494880 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine Injection
Description: Treatment group receives Marcaine (Bupivacaine) injected into one breast following breast reduction surgery and a saline injection in the other group.
Study NCT00683631 — intervention group
Intervention type: OTHER
Intervention: TheraSphere HUD
Description: TheraSphere is FDA approved under a Humanitarian Use Device. It is considered a brachytherapy device that delivers intra-arterial radiation therapy using yttrium-90 microspheres directly to liver tumors.
Study NCT03667209 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pain neuroscience education (PNE) and traditional exercise
Description: PNE will cover the neurophysiology of pain, transition from acute to chronic pain and the nervous system ability to modulate the pain experience.~Exercise of the neck and scapular regions, including strength, motor control and stretching exercises.~Initially (first 3 sessions) will be delivered individually and then (last 3 sessions)in small groups (4 participants). A total of 6 sessions will be delivered during 6 weeks. Each session will take around 1 hour.
Study NCT03667209 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pain neuroscience education (PNE) and suspension exercise
Description: PNE will cover the neurophysiology of pain, transition from acute to chronic pain and the nervous system ability to modulate the pain experience.~Exercise of the neck and scapular regions, including strength, motor control and stretching exercises. delivered in suspension.~Initially (first 3 sessions) will be delivered individually and then (last 3 sessions)in small groups (4 participants). A total of 6 sessions will be delivered during 6 weeks. Each session will take around 1 hour.
Study NCT06317090 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: guided bone regeneration
Description: a non-resorbable membrane was used as a space maintainer, filled with a particulated bone graft.
Study NCT04005365 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propranolol
Description: add propranolol in gastric cancer patients who need to receive preoperate chemotherapy
Study NCT04461158 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Patient Navigator Services
Description: The navigator services most commonly provided include facilitation and coordination of care, practical support, including transportation and financial assistance, appointment scheduling and reminders, education and psychosocial support
Study NCT03122197 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole Oral Tablet
Description: Administration: Letrozole will be given orally once daily.
Study NCT03122197 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: 50 mg/m2 TMZ administered orally once daily
Study NCT00565357 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Silicone Earplugs
Description: Silicone earplugs worn from within 1 week of birth through 35 weeks post-menstrual age or hospital discharge, whichever came first
Study NCT00565357 — intervention group
Intervention type: OTHER
Group type: NO_INTERVENTION
Intervention: Control
Description: Standard care in the neonatal intensive care unit
Study NCT01750840 — intervention group
Intervention type: DEVICE
Intervention: Biomet® EBI Bone Healing System
Description: A pulsed electromagnetic fields electrical stimulation device used for the treatment of fracture nonunions. Designed to be used for 3-10 hours per day with a recommended use of 10 hours per day.
Study NCT01750840 — intervention group
Intervention type: DEVICE
Intervention: Biomet Orthopak® Non-Invasive Bone Growth Stimulator System
Description: A capacitive coupling electrical stimulation device used for the treatment of fracture nonunions. Designed to be used for 24 hours per day.
Study NCT01750840 — intervention group
Intervention type: DEVICE
Intervention: Biomet SpinalPak® Non-Invasive Spine Fusion Stimulator
Description: A capacitive coupling electrical stimulation device used as an adjunctive treatment to lumbar spinal fusion. Designed to be used for 24 hours per day.
Study NCT02737176 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tobacco cessation intervention
Description: The nicotine dependence status is evaluated by the Fagerstrom Test for Nicotine Dependence test; those who 3 or more score are eligible for the intervention.~During the study, attending doctors implement a tobacco cessation intervention with standard treatments for above oral diseases.~Even if the subjects failed to abstain from smoking, the treatment is continued.~In case of the use of the nicotine replacement therapy, The investigators supply NRTs (nicotine patch or gum) for 2 weeks as a free of charge, and later the subjects themselves purchase it as over the counter (OTC) drugs at a pharmacy.
Study NCT01224106 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gantenerumab
Description: Participants received Gantenerumab at 105 mg , 225 mg, or at doses up to 1200 mg SC injection Q4W.
Study NCT01224106 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Gantenerumab
Description: Participants received Gantenerumab at 105 mg , 225 mg, or at doses up to 1200 mg SC injection Q4W.
Study NCT01224106 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants received Placebo SC injection Q4W.
Study NCT03320486 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapaconazole
Description: Application of 1 to 3 grams, depending on the lesion extension, per affected foot.
Study NCT03320486 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketoconazole
Description: Application of 1 to 3 grams, depending on the lesion extension, per affected foot.
Study NCT01174589 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Strength training
Description: to compare if there is a difference between 6 or 12 weeks of physical strength training
Study NCT04165304 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: sugar reduction
Description: sugar reduction in the offered drinks
Study NCT02666040 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ULTRAPRO® meshes
Description: The inguinal hernia repair has to be performed with the Lichtenstein technique, with standardized prosthesis fixation and no use of plug.
Study NCT02666040 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Prolene® meshes
Description: The inguinal hernia repair has to be performed with the Lichtenstein technique, with standardized prosthesis fixation and no use of plug.
Study NCT02666040 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Detecting the mode of admission to hospital
Description: Ordinary admission or day surgery
Study NCT02666040 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Detecting the mode of admission to hospital
Description: Ordinary admission or day surgery
Study NCT02666040 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Duration of surgery
Description: Time operating room
Study NCT03309306 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Natural Environment/Reduce Food Waste
Description: Participants will use the FoodImage app to capture data on food purchases, food waste that occurs during food preparation, food waste that is present after eating, and food waste from food purges in free-living conditions. Participants will use the app to record food waste for approximately 4-7 days over the subsequent week. They will also be provided with the following:~1. Feedback on the amount of food waste their household created during the first week,~2. A goal to reduce the next week's food waste by 20% or more, and~3. Tips on how to reduce household food waste adapted from current consumer campaigns
Study NCT03328078 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Emavusertib
Description: Emavusertib will be provided as a tablet dosage form to be taken BID.
Study NCT03328078 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibrutinib
Description: Ibrutinib will be provided as a tablet or capsule dosage form to be taken QD.
Study NCT02666040 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Duration of surgery
Description: Time operating room
Study NCT02666040 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Anesthesia volume and type used
Description: Anesthesias used: infiltration, followed by spinal, general, epidural.
Study NCT02666040 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Anesthesia volume and type used
Description: Anesthesias used: infiltration, followed by spinal, general, epidural.
Study NCT04803019 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: DEB-TACE
Description: The chemotherapy used in this arm is the Doxorubicin that will be carried into the tumor by Embozene TANDEM® (Boston Scientific) microspheres. TANDEM® embozene microspheres are made of non-resorbable, biocompatible, hydrogel microspheres, subjected to precision calibration and coated with an inorganic perfluorate polymer (Polyzene®-F).~TANDEM® embozene microspheres are available in three different sizes, in 2 ml and 3 ml volumes of product and are supplied in preloaded vials and syringes.The maximum loadable amount on the hydrospheres 50 mg of Doxorubicina for ml. The maximum injectable dose of Doxorubicin for each treatment is 150 mg and therefore the maximum amount of microspheres that can be used for each treatment is 3 ml. The size of microspheres that will be used in this study is up to 100 ± 25 μm.
Study NCT04803019 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: TAE
Description: The TAE will be performed with Embozene microspheres (Boston Scientific). Embozene microspheres are spherical particles of hydrogel, precisely calibrated, biocompatible, non-absorbable and coated with a perfluorinated inorganic polymer (Polyzene®-F). This medical device is available in various sizes; in this study, to avoid that the particle size exceeds the one used for the treatment of arm A, it will be possible to use microspheres with dimensions up to 100 μm (range 75 ± 125 μm).~Embozene microspheres are offered in vials containing 1 ml of suspended product in physiological saline solution for apyrogenic sterile transport. The total volume of the Embozene microspheres, including the transport solution, is about 7 ml. To this product it is necessary to add an appropriate amount of non-ionic contrast medium in order to obtain a homogeneous suspension and with good visibility during the injection under fluoroscopy.
Study NCT03597503 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SPN-810
Description: Flexible dose
Study NCT03597503 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT02976545 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: fMRI (functional Magnetic Resonance Imaging)
Description: fMRI examination
Study NCT02976545 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: psychiatric evaluation
Description: psychiatric evaluation
Study NCT01319513 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: whey protein bolus
Description: single dose of 25 g whey protein
Study NCT01319513 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: whey protein pulses
Description: 10 2.5 g pulses of whey protein
Study NCT03419845 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Step Right Buddy
Description: The Step Right Buddy, which is under investigation in this clinical study, is an elasticated band that attached by Velcro to the back legs of a standard walking frame. The purpose of the Step Right Buddy is to provide sensory feedback to standard walking frame users of how far to step in to the frame and to encourage them to move the frame forward.
Study NCT04181957 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral tablet
Description: Participants take one dose of placebo (lactose) tablet.
Study NCT04181957 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lisdexamfetamine Dimesylate
Description: Participants take one 50mg tablet of lisdexamfetamine dimesylate once.
Study NCT00784082 — intervention group
Intervention type: DRUG
Intervention: Hydroxycarbamide, Hydroxyurea (drug)
Description: hydroxyurea 20-25 mg/kg/day since at least 3 months
Study NCT04884945 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Open Pyeloplasty (OP)
Description: Open approach for the surgical correction of UPJ obstruction
Study NCT04884945 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Robotic-Assisted Laparoscopic Pyeloplasty (RALP)
Description: Robotic approach with the da Vinci Surgical System for the surgical correction of UPJ obstruction
Study NCT00656760 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PET/CT
Description: PET/CT is being performed on all patients in the study.
Study NCT02021851 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone and aprepitant
Study NCT02021851 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Dexamethasone and ondansetron
Study NCT00614991 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Raltegravir
Description: 400mg BID
Study NCT00614991 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fosamprenavir
Description: 1400mg BID, 700 mg BID or 1400 mg QD
Study NCT00614991 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ritonavir
Description: 100 mg BID or QD
Study NCT02067468 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HPV test
Description: QIAGEN - The Digene HPV test®
Study NCT02067468 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: COLPOSCOPY
Description: Colposcopy routine health services
Study NCT02067468 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: COLPOSCOPY
Description: Colposcopy routine health services
Study NCT02067468 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: cytology
Description: Cytology routine health services
Study NCT03753763 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Safinamide Methanesulfonate
Description: 100 mg (free base)
Study NCT03753763 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Safinamide Methanesulfonate matching placebo
Description: 100 mg placebo
Study NCT04330716 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Genetic Counseling
Description: Standard of care genetic counseling
Study NCT04330716 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Educational Video
Description: Video tutorial about genetic testing
Study NCT03139227 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bio specimen Collection
Description: Patients undergo collection of blood and urine
Study NCT03139227 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dietary Intervention
Description: Consume celery-banana bread
Study NCT03139227 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT00901862 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Pulsed magnetic fields (Quantum MH-2MR bracelet)
Description: Pulsed magnetic fields
Study NCT00901862 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham pulsed magnetic fields (Quantum MH-2MR bracelet)
Description: Hybrid circuits crucial for the generation of the electromagnetic field had been removed.
Study NCT03587922 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Fantom
Description: Treatment of den ovo coronary lesions
Study NCT05440487 — intervention group
Intervention type: OTHER
Intervention: Iron chelator
Description: There is no treatment allocation. Patients administered approved Iron chelators by prescription that have started before inclusion of the patient into the study will be enrolled.
Study NCT03366597 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Description: 1.5%-3% Sevoflurane will be given during the cardiac surgery except cardiopulmonary bypass.
Study NCT02420990 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Medication Integration Protocol (MIP)
Study NCT02420990 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Changing Academic Support in the Home for Adolescents with ADHD (CASH-AA)
Study NCT02420990 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Changing Academic Support in the Home for Adolescents with ADHD (CASH-AA)
Study NCT05300854 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard anesthesia in addition to serratus plane block
Description: a US-guided SPB was performed after induction of general anesthesia with the patient lying supine.
Study NCT05300854 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard anesthesia in addition to para-vertebral block
Description: Standard anesthesia in addition to para-vertebral block
Study NCT05620069 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music listening
Description: Participants are asked to select one of four music playlists and listen to it for appr. 30 minutes at bedtime during the intervention period.
Study NCT03197350 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: cMR
Description: cardiac MRI done to complete the diagnosis
Study NCT03197350 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: biomarker
Description: Biomarker correlation with cMR parameters Prognostic information
Study NCT02835898 — intervention group
Intervention type: OTHER
Intervention: Conventional periodontal treatment
Description: Conventional routine periodontal treatment will be done for patients in test group
Study NCT02417675 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Community-based Adherence Clubs
Description: Women in the AC arm are prescribed 2 months of their current ART medication (compared to 1 month in the SOC) and will be advised to go to the AC office immediately, where they will be scheduled for their first session. Women will attend AC meetings every two months. At these meetings, women will receive a 2 month supply of medication, health education and peer-support. A trained Community Health Worker (CHW) will also collect blood samples, weight, and current signs/symptoms from women.~Each participant has 5 working days after their AC session to come and collect her medication. Those who have defaulted will be followed up by the CHW via phone calls and, possibly, home visits. If reached, women will be told to return immediately to the main ART facility for receipt of ART care.
Study NCT02417675 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care for Mothers
Description: Women will be referred immediately from the maternity ART clinic to their nearest adult ART clinic at their first postpartum clinic visit. At referral, they receive an initial 1-month supply of their current ART medication. At the first appointment after transfer into the general ART service, patients undergo clinical history and examination by a doctor or clinical nurse practitioner. Laboratory investigations are ordered according to standard protocols or based on clinician discretion. For the 1st 4 months in the new service, stable patients are dispensed 1 month of ART; subsequent visits are 2-monthly for medication refill, with clinician review 6-monthly; patients with particular clinical or psychosocial concerns may be reviewed more regularly, or referred to higher levels of care.
Study NCT02417675 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard of Care for Infants
Description: All infants will receive care at their nearest primary care clinic. Following national protocols, all HIV-infected mothers are issued a 6-week supply of nevirapine syrup after delivery and counselled on daily nevirapine prophylaxis. Infant follow-up takes place within 1 week postpartum with the mother (at the MOU) and then at 6 weeks postpartum (at the nearest primary care clinic) when HIV PCR testing of the infant is carried out. Following national protocols, infants who are breastfed beyond 6 weeks receive HIV PCR testing 2-4 weeks after the cessation of breastfeeding, again conducted at the nearest City of Cape Town primary care clinic.
Study NCT02417675 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care for Infants
Description: All infants will receive care at their nearest primary care clinic. Following national protocols, all HIV-infected mothers are issued a 6-week supply of nevirapine syrup after delivery and counselled on daily nevirapine prophylaxis. Infant follow-up takes place within 1 week postpartum with the mother (at the MOU) and then at 6 weeks postpartum (at the nearest primary care clinic) when HIV PCR testing of the infant is carried out. Following national protocols, infants who are breastfed beyond 6 weeks receive HIV PCR testing 2-4 weeks after the cessation of breastfeeding, again conducted at the nearest City of Cape Town primary care clinic.